Lymphocyte count as a predictor of severity of COVID-19 infection

Background: Recent researches suggest that hematological profiles vary during SARS-CoV-2 infection. Patients with COVID-19 have a lower peripheral blood lymphocyte count in the early stages of disease. Aim study: To evaluate if level at admission can be used as predictor for severity and mortality Methods: A prospective observational study was conducted ward Al-Khidhir General Hospital period one year. It included 350 patients who diagnosed infection admitted isolation wards. Complete including WBC, hemoglobin, platelet count, neutrophil monocyte were assessed. Severity disease categorized into mild, moderate, severe, critical. Results: In this study, severe had significant means (0.84 versus 1.73 *109/µl, P= 0.001). The cut point N/L ratio 1.0 *109/µl. Hence, < 109/µl is predictive or critical stage COVID-19. Conclusion: Hematological indices are easy cheap way assessing clinical progress One parameter which show our correlation between stage. Lower to sever form